Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients

American Journal of Kidney Diseases

Volumn 60, Issue 4, 2012, Pages 539-547

  Ibrahim, Fowzia ^a   Hamzah, Lisa ^a   Jones, Rachael ^b   Nitsch, Dorothea ^c,d   Sabin, Caroline ^e   Post, Frank A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

chronic kidney disease; Chronic Kidney Disease Epidemiology Collaboration (CKD EPI); competing risk; Estimated glomerular filtration rate (eGFR); human immunodeficiency virus (HIV); mortality

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; ETHNICITY; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MORTALITY; OBSERVATIONAL STUDY; PREDICTION; RISK FACTOR;

AIDS-ASSOCIATED NEPHROPATHY; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; YOUNG ADULT;

EID: 84866423256     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.03.006     Document Type: Article

References (58)

1. F.J. Palella Jr, K.M. Delaney, A.C. Moorman Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection HIV Outpatient Study Investigators N Engl J Med 338 13 1998 853 860
2. A. Mocroft, B. Ledergerber, C. Katlama Decline in the AIDS and death rates in the EuroSIDA study: an observational study Lancet 362 9377 2003 22 29
3. B. Marin, R. Thiebaut, H.C. Bucher Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy AIDS 23 13 2009 1743 1753
4. Antiretroviral Therapy Cohort Collaboration Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies Clin Infect Dis 50 10 2010 1387 1396
5. C. Grunfeld, J.A. Delaney, C. Wanke Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM Study AIDS 23 14 2009 1841 1849
6. P.Y. Hsue, P.W. Hunt, A. Schnell Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis AIDS 23 9 2009 1059 1067
7. L.A. Kingsley, J. Cuervo-Rojas, A. Munoz Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study AIDS 22 13 2008 1589 1599
8. K.V. Fitch, J. Lo, S. Abbara Increased coronary artery calcium score and noncalcified plaque among HIV-infected men: relationship to metabolic syndrome and cardiac risk parameters J Acquir Immune Defic Syndr 55 4 2010 495 499
9. F.A. Post, S.G. Holt Recent developments in HIV and the kidney Curr Opin Infect Dis 22 1 2009 43 48
10. L.A. Szczech, C. Grunfeld, R. Scherzer Microalbuminuria in HIV infection AIDS 21 8 2007 1003 1009
11. F.A. Post, L.J. Campbell, L. Hamzah Predictors of renal outcome in HIV-associated nephropathy Clin Infect Dis 46 8 2008 1282 1289
12. L.A. Szczech, S.K. Gupta, R. Habash The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection Kidney Int 66 3 2004 1145 1152
13. M.G. Atta, G.M. Lucas, D.M. Fine HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management Expert Rev Anti Infect Ther 6 3 2008 365 371
14. J. Neuhaus, D.R. Jacobs Jr, J.V. Baker Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection J Infect Dis 201 12 2010 1788 1795
15. S.G. Deeks, A.N. Phillips HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity BMJ 338 2009 a3172
16. L.H. Kuller, R. Tracy, W. Belloso Inflammatory and coagulation biomarkers and mortality in patients with HIV infection PLoS Med 5 10 2008 e203
17. J.V. Baker, J. Neuhaus, D. Duprez Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection J Acquir Immune Defic Syndr 56 1 2011 36 43
18. P.C. Tien, A.I. Choi, A.R. Zolopa Inflammation and mortality in HIV-infected adults: analysis of the FRAM Study cohort J Acquir Immune Defic Syndr 55 3 2010 316 322
19. P. Muntner, J. He, L. Hamm, C. Loria, P.K. Whelton Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States J Am Soc Nephrol 13 3 2002 745 753
20. M. Tonelli, N. Wiebe, B. Culleton Chronic kidney disease and mortality risk: a systematic review J Am Soc Nephrol 17 7 2006 2034 2047
21. K. Matsushita, M. van der Velde, B.C. Astor Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 9731 2010 2073 2081
22. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 2004 1296 1305
23. D.S. Keith, G.A. Nichols, C.M. Gullion, J.B. Brown, D.H. Smith Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Arch Intern Med 164 6 2004 659 663
24. A.I. Choi, Y. Li, S.G. Deeks, C. Grunfeld, P.A. Volberding, M.G. Shlipak Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons Circulation 121 5 2010 651 658
25. E. George, G.M. Lucas, G.N. Nadkarni, D.M. Fine, R. Moore, M.G. Atta Kidney function and the risk of cardiovascular events in HIV-1-infected patients AIDS 24 3 2010 387 394
26. L.J. Campbell, F. Ibrahim, M. Fisher, S.G. Holt, B.M. Hendry, F.A. Post Spectrum of chronic kidney disease in HIV-infected patients HIV Med 10 6 2009 329 336
27. M.M. Estrella, R.S. Parekh, A. Abraham The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women J Acquir Immune Defic Syndr 55 2 2010 217 220
28. L.B. Mulenga, G. Kruse, S. Lakhi Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia AIDS 22 14 2008 1821 1827
29. A. Choi, R. Scherzer, P. Bacchetti Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons Am J Kidney Dis 56 5 2010 872 882
30. M.G. Atta, D.M. Fine, G.D. Kirk, S.H. Mehta, R.D. Moore, G.M. Lucas Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland Clin Infect Dis 45 12 2007 1625 1632
31. L.I. Gardner, S.D. Holmberg, J.M. Williamson Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women J Acquir Immune Defic Syndr 32 2 2003 203 209
32. A.I. Choi, R.A. Rodriguez, P. Bacchetti, D. Bertenthal, P.A. Volberding, A.M. O'Hare Racial differences in end-stage renal disease rates in HIV infection versus diabetes J Am Soc Nephrol 18 11 2007 2968 2974
33. L. Bansi, A. Hughes, S. Bhagani Clinical epidemiology of HIV-associated end-stage renal failure in the UK AIDS 23 18 2009 2517 2521
34. UK Collaborative HIV Cohort Steering Committee The creation of a large UK-based multicentre cohort of HIV-infected individuals: the UK Collaborative HIV Cohort (UK CHIC) Study HIV Med 5 2 2004 115 124
35. A.S. Levey, L.A. Stevens, C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
36. F. Ibrahim, L. Hamzah, R. Jones, D. Nitsch, C. Sabin, F.A. Post Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients [published online ahead of print November 25, 2011] Nephrol Dial Transplant 2011 10.1093/ndt/gfr657
37. A.S. Levey, J. Coresh, T. Greene Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values Clin Chem 53 4 2007 766 772
38. J. Roe, L.J. Campbell, F. Ibrahim, B.M. Hendry, F.A. Post HIV care and the incidence of acute renal failure Clin Infect Dis 47 2 2008 242 249
39. A. Reid, W. Stohr, A.S. Walker Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy Clin Infect Dis 46 8 2008 1271 1281
40. National Kidney Foundation KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification http://www.kidney.org/professionals/KDOQI/guidelines-ckd/toc.htm 2002 Accessed October 1, 2011
41. M. Lunn, D. McNeil Applying Cox regression to competing risks Biometrics 51 2 1995 524 532
42. M.S. Shiels, S.R. Cole, J.S. Chmiel A comparison of ad hoc methods to account for non-cancer AIDS and deaths as competing risks when estimating the effect of HAART on incident cancer AIDS among HIV-infected men J Clin Epidemiol 63 4 2010 459 467
43. R. Agarwal, Z. Bunaye, D.M. Bekele, R.P. Light Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease Am J Nephrol 28 4 2008 569 575
44. Succi R, Gouvea A, Machado DM, et al. Can glomerular hyperfiltration measurement predict later development of HIVassociated nephropathy? Poster presented at: 28th Annual Meeting of the European Society for Paediatric Infectious Diseases; May 4-8, 2010; Nice, France.
45. H.J. Cox, S. Bhandari, A.S. Rigby, E.S. Kilpatrick Mortality at low and high estimated glomerular filtration rate values: a 'U' shaped curve Nephron Clin Pract 110 2 2008 c67 c72
46. G.M. Lucas, B. Lau, M.G. Atta, D.M. Fine, J. Keruly, R.D. Moore Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races J Infect Dis 197 11 2008 1548 1557
47. G.M. Lucas, S.H. Mehta, M.G. Atta End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004 AIDS 21 18 2007 2435 2443
48. G.M. Lucas, W. Clarke, J. Kagaayi Decreased kidney function in a community-based cohort of HIV-infected and HIV-negative individuals in Rakai, Uganda J Acquir Immune Defic Syndr 55 4 2010 491 494
49. A.I. Choi, R.A. Rodriguez, P. Bacchetti, D. Bertenthal, P.A. Volberding, A.M. O'Hare The impact of HIV on chronic kidney disease outcomes Kidney Int 72 11 2007 1380 1387
50. N. Papeta, K. Kiryluk, A. Patel APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy J Am Soc Nephrol 22 11 2011 1991 1996
51. J.B. Kopp, G.W. Nelson, K. Sampath APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy J Am Soc Nephrol 22 11 2011 2129 2137
52. D.M. Fine, W.G. Wasser, M.M. Estrella APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease J Am Soc Nephrol 23 2 2012 343 350
53. A. Mocroft, O. Kirk, P. Reiss Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients AIDS 24 11 2010 1667 1678
54. G.M. Lucas, J.A. Eustace, S. Sozio, E.K. Mentari, K.A. Appiah, R.D. Moore Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study AIDS 18 3 2004 541 546
55. A. Choi, R. Rodriguez, P. Bacchetti Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease Clin Infect Dis 45 12 2007 1633 1639
56. P.J. Peters, D.M. Moore, J. Mermin Antiretroviral therapy improves renal function among HIV-infected Ugandans Kidney Int 74 7 2008 925 929
57. A.I. Choi, M.G. Shlipak, P.W. Hunt, J.N. Martin, S.G. Deeks HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy AIDS 23 16 2009 2143 2149
58. + count-guided interruption of antiretroviral treatment N Engl J Med 355 22 2006 2283 2296